Recent Finacing
Recent Raise
ImmuneAGE Bio develops an HSC-targeted drug-discovery platform enabling large-scale ex vivo combinatorial screening and HSC expansion, advancing oral immune boosters and ex vivo rejuvenation cocktails for transplant and chemotherapy recovery.
